Skip to main content
. 2014 Aug 26;19(8):1305–1316. doi: 10.1007/s00775-014-1187-5

Fig. 3.

Fig. 3

Effect of the ruthenium complexes treatment towards mammary cancer cells. a, c, e: DIC (differential interferential contrast), b, d, e: fluorescence labeling of the nuclei by Hoechst 33258 of the 4T1 cells after treatment by 8 µM [Ru(dip)2(CH3bpy-DCU)]2+ (c, d) or [Ru(dip)2(bpy)]2+ (e, f), for 24 h. a and b show control cells